Abstract
Axillary staging for breast cancer is vitally important for determining appropriate adjuvant hormone and chemotherapy. In the absence of distant metastases, axillary lymph node status remains the most accurate predictor of clinical outcome. Sentinel lymph node biopsy is a minimally invasive approach with enhanced accuracy and less morbidity than conventional axillary dissection. The stage is now set for the sentinel lymphadenectomy staging to move from state-of-the-art care to the standard care in coming years. (C) 2000 by Excerpta Medica, Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 262-267 |
Number of pages | 6 |
Journal | American journal of surgery |
Volume | 180 |
Issue number | 4 |
DOIs | |
State | Published - 2000 |
ASJC Scopus subject areas
- Surgery